TP53 and neoplasm: Pituitary tumor remained stable after osilodrostat initiation in all patients except for a patient with a pituitary tumor with an initial microadenoma (operated in January 2003, pathological results: ki 67 of 10%, positive p53) who experience a recurrence in June 2019 with no initial visible tumor.